Abiopharma

🔍 Budge James (Executive)

Company: Hinge Health, Inc. (HNGE)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 4,614 shares of Class A Common Stock at $44.6 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 392,199.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.